Point72 Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-105,000
| Closed | -$263K | – | 1392 |
|
2023
Q4 | $263K | Buy |
+105,000
| New | +$263K | ﹤0.01% | 1082 |
|
2021
Q4 | – | Sell |
-895,200
| Closed | -$3.84M | – | 995 |
|
2021
Q3 | $3.84M | Sell |
895,200
-104,800
| -10% | -$450K | 0.02% | 660 |
|
2021
Q2 | $3.03M | Sell |
1,000,000
-37,700
| -4% | -$114K | 0.01% | 634 |
|
2021
Q1 | $3.46M | Buy |
+1,037,700
| New | +$3.46M | 0.02% | 602 |
|
2020
Q1 | – | Sell |
-1,897,284
| Closed | -$5.27M | – | 717 |
|
2019
Q4 | $5.27M | Buy |
+1,897,284
| New | +$5.27M | 0.03% | 459 |
|
2017
Q4 | – | Sell |
-224,655
| Closed | -$1.39M | – | 738 |
|
2017
Q3 | $1.39M | Buy |
+224,655
| New | +$1.39M | 0.01% | 592 |
|
2015
Q3 | – | Sell |
-360,800
| Closed | -$4.28M | – | 688 |
|
2015
Q2 | $4.28M | Buy |
360,800
+203,600
| +130% | +$2.41M | 0.03% | 432 |
|
2015
Q1 | $2.75M | Buy |
+157,200
| New | +$2.75M | 0.02% | 484 |
|